FDA grants full approval for combination leukemia treatment

October 19th 2020

Venclexta was previously granted provisional approval by FDA in late 2018.

Pfizer: COVID-19 vaccine likely ready late November

October 19th 2020

The pharma maker plans to apply for FDA Emergency Use Authorization for the vaccine after the third week of November.

US government, AstraZeneca team up on COVID-19 preventative med

October 13th 2020

The pharma maker aims to make the treatment available to the most vulnerable populations by December.

RA drug indication expanded to other pediatric autoimmune disorders

October 13th 2020

Simponi Aria is now approved to to treat patients 2 years and older with active polyarticular juvenile Idiopathic arthritis (pJIA) and psoriatic arthritis (PsA).

FDA clears first treatment for mesothelioma in 16 years

October 6th 2020

The combination therapy of Opdivo plus Yervoy will treat the cancer caused by inhaling asbestos fibers.

Pfizer snags fourth indication for blockbuster Xeljanz

September 29, 2020

Pfizer snagged its fourth indication for the blockbuster medication tofacitinib (Xeljanz) for children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA).